0001127602-12-025775.txt : 20120905 0001127602-12-025775.hdr.sgml : 20120905 20120905161506 ACCESSION NUMBER: 0001127602-12-025775 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120904 FILED AS OF DATE: 20120905 DATE AS OF CHANGE: 20120905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERSTEIN DAVID L CENTRAL INDEX KEY: 0001242986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21696 FILM NUMBER: 121074148 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-09-04 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242986 BERSTEIN DAVID L C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 Senior VP, Chief IP Officer Common Stock 2012-09-04 4 M 0 8050 5.23 A 221906 D Common Stock 2012-09-04 4 S 0 8050 21.00 D 213856 D Common Stock 2012-09-04 4 S 0 8000 21.00 D 205856 D Employee Stock Option (Right to Buy) 5.23 2012-09-04 4 M 0 8050 0 D 2006-09-09 2014-09-09 Common Stock 8050 41950 D Shares were aquired upon the exercise of outstanding stock options at $5.23 per share. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 22, 2011. /s/Edward M. Fitzgerald, Attorney-in-Fact 2012-09-05